3780
K. Wahlstro¨m et al. / Tetrahedron Letters 49 (2008) 3779–3781
resulting in the generation of N,N 0-dimethylimidazolidi-
none and the free phenol.
more than one Nmec protected tyrosine residue, it is
important that the peptide should remain in solution dur-
ing the cleavage as the solubility will be reduced when
the cationic Nmec group is cyclized to N,N0-dimethylimi-
dazolidinone. The selection of solvents for this reaction is
therefore highly dependent on the sequence of the peptide,
but in general we found that combinations of DMF and
water gave the most reliable results.
To demonstrate the potential value of the Nmec group
in the synthesis of hydrophobic peptides, the peptide H-
Ala-Tyr-Val-Leu-Tyr-Tyr-Ala-OH, was synthesized using
Boc-Nmec protection of all the tyrosine residues. The
HPLC elution profile of the crude product is shown in Fig-
ure 2.
The expected Nmec-protected peptide was obtained as
the major product. The purified Nmec- protected peptide
was dissolved in 30% DMF/water (1 mg/ml) and 10 equiv
of N-methyl morpholine was added. N-Methylmorpholine
is a weak non-nucleophilic base (pKa 7.41), and these mild
reaction conditions will minimize base-catalyzed side-reac-
tions. The cyclization reaction was monitored by removing
small samples at different time points, quenching with ace-
tic acid, and concentrating in vacuo. After being redis-
solved in 30% acetonitrile, the samples were analyzed by
HPLC. The cyclization reaction was complete after 4 h.
As expected, cleavage of the Nmec group resulted in signif-
Taken together, these reports suggest that tyrosine resi-
dues with a Boc-N-methyl-N-[2-(methylamino)ethyl]car-
bamoyl group (Boc-Nmec) as a side chain-protective
group for tyrosine residues could be expected to be stable
under the reaction conditions in Fmoc SPPS. After treat-
ment with TFA, the Boc group is cleaved but the proton-
ated Nmec group would still be attached to the peptide,
resulting in increased solubility. After purification, the
unprotected peptide can be obtained by short exposure to
a weak alkaline aqueous solution.
We therefore synthesized Fmoc-Tyr(Boc-N-methyl-
N-[2-(methylamino)ethyl]carbamoyl)-OH, Fmoc-Tyr(Boc-
Nmec)-OH (3), as shown in Figure 1. The phenacyl ester
of Fmoc-Tyr-OH (1) was treated with a slight excess of
p-nitrophenyl chloroformate and diisopropylethylamine
(DIPEA) in methylene chloride for 30 min followed by a
threefold excess of mono-Boc protected N,N0-dimethyleth-
ylenediamine and DIPEA. After aqueous work-up and dry
flash chromatography, the phenacyl ester 2 was cleaved
with zinc in acetic acid. Additional work-up and crystalli-
zation from ethyl acetate/petroleum ether gave the final
product with an overall yield of 89%.6
The product was characterized by 1H and 13C NMR and
the results were in agreement with the expected structure
(see Supplementary data).
The stability of the Boc-Nmec group in 20% piperidine
in DMF was studied by treating the peptide H-Ala-Tyr-
(Boc-Nmec)-Phe-Lys(Boc)-Lys(Boc)-OH attached to the
Wang resin for 24 h. After cleavage with TFA, the major
product was the Nmec-protected peptide. No significant
increase in the levels of by-products as compared to the
peptide not exposed to prolonged piperidine treatment
was observed by HPLC analysis and MALDI-TOF mass
spectrometry. These results are in agreement with those
obtained by Vontor et al. who determined the half-life of
phenyl N,N-dimethylcarbamate in 1 M aqueous NaOH at
40 °C to be 20 min.7 It can therefore be concluded that
the Boc-Nmec group will be stable to piperidine treatment
even during the synthesis of large peptides.
The rate of removal of the Nmec group will be depen-
dent on the peptide sequence, the pH, the temperature,
and the solvent. Saari et al. recorded a half-life of 36 min-
utes at pH 7.4 and 37 °C for Nmec-protected hydroxyani-
sole in aqueous solution.5 For peptides that are prone to
aggregation, especially very hydrophobic peptides with
Fig. 2. HPLC elution profile of the model peptide H-Ala-Tyr-Val-Leu-
Tyr-Tyr-Ala-OH synthesized by Boc-Nmec protection of the side chains
of all the tyrosine residues. (A) H-Ala-Tyr(Nmec)-Val-Leu-Tyr(Nmec)-
Tyr(Nmec)-Ala-OH after cleavage with TFA. (B) H-Ala-Tyr-Val-Leu-
Tyr-Tyr-Ala-OH after treatment of the purified peptide for 4 h with 30%
DMF/water and 10 equiv of N-methylmorpholine.
Fig. 1. Synthesis of Fmoc-Tyr(Boc-Nmec)-OH. Reagents: (a) (1) p-nitrophenyl chloroformate, DIPEA, DCM; (2) mono-Boc- N,N0-dimethylethylene-
diamine, DIPEA, DCM; (b) Zn/HOAc.